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Abstract 
Purpose: To develop and validate a deep learning model for the automatic 
segmentation of geographic atrophy (GA) in color fundus images (CFIs) and its 
application to study growth rate of GA. 
Design: Prospective, multicenter, natural history study with up to 15 years of 
follow up. 
Participants: 409 CFIs of 238 eyes with GA from the Rotterdam Study (RS) and 
the Blue Mountain Eye Study (BMES) for model development, and 5,379 CFIs of 625 
eyes from the Age-Related Eye Disease Study (AREDS) for analysis of GA growth rate. 
Methods: A deep learning model based on an ensemble of encoder-decoder 
architectures was implemented and optimized for the segmentation of GA in CFIs. Four 
experienced graders delineated, in consensus, GA in CFIs from RS and BMES. These 
manual delineations were used to evaluate the segmentation model using 5-fold cross-
validation. The model was further applied to CFIs from the AREDS to study the growth 
rate of GA. Linear regression analysis was used to study associations between structural 
biomarkers at baseline and GA growth rate. A general estimate of the progression of GA 
area over time was made by combining growth rates of all eyes with GA from the AREDS 
set. 
Main Outcome Measures: Automatically segmented GA and GA growth rate. 
Results: The model obtained an average Dice coefficient of 0.72 ± 0.26 on the 
BMES and RS set while comparing the automatically segmented GA area to the graders' 
manual delineations. An intraclass correlation coefficient of 0.83 was reached between 
the automatically estimated GA area and the graders' consensus measures. Eight 
automatically calculated structural biomarkers (area, filled area, convex area, convex 
solidity, eccentricity, roundness, foveal involvement and perimeter) were significantly 
associated with growth rate. Combining all growth rates indicated that GA area grows 
quadratically up to an area of around 12 mm², after which growth rate stabilizes or 
decreases. 
Conclusion: The presented deep learning model allowed for fully automatic and 
robust segmentation of GA in CFIs. These segmentations can be used to extract 
structural characteristics of GA that predict its growth rate.  
Introduction 
Geographic atrophy (GA) occurs in the advanced stage of age-related macular 
degeneration (AMD). It is characterized by progressive atrophy of the retinal pigment 
epithelium, overlying photoreceptors, and underlying choriocapillaris.1 Areas of GA often 
initially appear extrafoveal, where they may cause difficulties in reading or dim-light 
vision.2 Over time the atrophic area may grow, and when it reaches the fovea, visual 
acuity is severely diminished. Prevalence of GA increases exponentially with age,3 and 
is highest in people of European ancestry.4 The number of people affected by GA is 
expected to increase further in the near future because of the ageing population.5 
Currently, no approved treatment exists to prevent progression of 
GA.6,7 However, several potential therapies are in clinical trial.8 For evaluation of these 
trials, reliable anatomic endpoints are required, as visual acuity alone provides 
insufficient insight in the severity of the disease.9 Growth rate of the atrophic area has 
been suggested as an important indicator of disease progression.9-11 However, the 
speed at which GA progresses varies greatly between subjects.12-14 Therefore, 
understanding the patterns associated with progression and the variability between 
subjects is important for the design and interpretation of clinical trials. 
To assess growth rate, accurate delineation of the GA area is required. However, 
as manual delineation can be challenging and time-consuming,15,16 automatic 
segmentation could provide a scalable and reproducible alternative. Deep learning has 
emerged as a powerful technique for the automatic analysis of medical images.17 Deep 
learning models require labeled examples (training data) to tune their internal 
parameters. The model then learns to extract features that are important for the 
segmentation task without further need of explicit domain knowledge from experts. It has 
been applied successfully to color fundus images (CFIs) for classification of severity 
stages in AMD18,19 or diabetic retinopathy,20 and recently also for the detection of 
GA.21 Although manually labeled examples are still required for training and validation, 
the model can thereafter be applied to large data sets without further intervention of 
expert ophthalmologists. 
These automatic methods also have the potential to efficiently and accurately 
extract structural characteristics of GA as seen in imaging that have been demonstrated 
to correlate with growth rate. For example, multifocal lesions grow faster than unifocal 
lesions22 and extrafoveal lesions grow faster than foveal lesions.13 Circular lesions have 
been demonstrated to grow at a slower rate than more irregularly shaped lesions.23. 
Baseline lesion area has been consistently associated with future growth, with larger 
lesions growing faster than smaller lesions.11,13,24,25 However, applying a square root 
transformation to the lesion size may remove this dependency.16,26 It is therefore 
hypothesized that lesions with approximate circular shape grow at a constant radial 
speed, thus leading to a quadratic growth of the area.16,27 
Various imaging modalities have been used to assess GA. CFIs are historically 
most widely used, particularly in large epidemiologic studies.12 More recently fundus 
autofluorescence (FAF) and optical coherence tomography (OCT) have also become 
popular for the study of GA and GA progression.13,16,25 Several lesion characteristics 
visible on those modalities can be linked to progression of GA. For example, banded or 
diffuse perilesional patters on FAF and structural abnormalities at the junctional zone on 
OCT have been associated with faster GA progression.13,25,28 Although GA may be 
detected earlier on FAF than CFI,29 good agreement on quantification of GA area in CFI 
between two independent reading centers has been demonstrated,11 and progression 
rates assessed from both FAF and CFI are highly correlated.13,29 CFI has the advantage 
that it is widely available, often over longer time periods, making it suitable for the study 
of long term progression of GA. Previous work on automatic methods for segmentation 
of GA focuses mainly on OCT30-32 or FAF.33 Feeny et al.34 proposed a method based on 
a random forest classifier in CFI. In contrast, in this study we present a model that is 
based on deep learning. To our best knowledge, this is the first deep learning model for 
segmentation of GA in CFI. 
The purpose of this study is two-fold: 1) to develop and validate a fully automatic 
model for segmentation of GA in CFIs. and 2) to demonstrate its utility in a longitudinal 
setting for the study of GA progression. The performance of the developed model is 
compared against four graders on a challenging dataset to evaluate its robustness. Next, 
the automatically segmented GA areas provide measures of structural characteristics 
related to lesion size, location and morphology. We investigate the associations between 
those structural characteristics at baseline and subsequent growth rate of GA. Finally, 
we combine GA growth rates across patients to obtain an estimate of average 
progression of GA area over time. 
Methods 
Data 
Data for development and evaluation of the deep learning model for GA 
segmentation were collected from the Blue Mountains Eye Study (BMES)35 and the 
Rotterdam Study (RS) cohorts I, II and III.36 The developed model was applied to CFIs 
from the Age-Related Eye Disease Study (AREDS)11 for the assessment of GA growth 
rate. 
The BMES is a population study from the Blue Mountains region in Australia that 
started between 1992 and 1994, and included 3,654 participants aged 49 or older. CFIs 
were obtained with a Zeiss fundus camera (Carl Zeiss, Oberkochen, Germany) for the 
first 3 visits and a CanonCF-60 DSi with DS Mark II body (Canon, Tokyo, Japan) for the 
4th visit. The BMES was approved by the University of Sydney and the Sydney West 
Area Health Service Human Research Ethics Committees. 
The RS is a population study from a suburb in Rotterdam, the Netherlands. RS 
cohort I started in 1990 and included 7,983 participants aged 55 years and older. Cohort 
II started in 2000 and included 3,011 participants aged 55 years and older. Cohort III 
started in 2006 and included 3,932 participants aged 45 years and older. CFIs for the 
first examinations were obtained with a Topcon TRV-50VT (Topcon Optical Company, 
Tokyo, Japan), the last two examinations with a Topcon TRC 50EX and a Sony DXC-
950P digital camera. The RS was approved by the Medical Ethics Committee of the 
Erasmus MC and by the Netherlands Ministry of Health, Welfare and Sport. 
The AREDS is a long-term, multicenter, prospective study of the clinical course 
of AMD and cataract. Starting between 1992 and 1998, 11 clinics in the United States 
enrolled 4,757 participants aged between 55 and 80 years. Stereoscopic CFIs were 
acquired with a Zeiss FF-series camera (Carl Zeiss AG, Oberkochen, Germany). The 
AREDS was approved by an independent institutional review board at each clinical 
center. 
The follow up interval for RS and BMES was five years. The AREDS had follow 
up at six months intervals, although the typical interval between available CFIs was one 
year. The BMES, RS and AREDS all adhere to the tenets of the Declaration of Helsinki. 
A total of 504 CFIs of patients diagnosed with AMD and signs of GA were included 
from the BMES and RS sets. 26 images with mixed signs of AMD (neovascularization, 
bleedings, scars) were excluded in order to disambiguate overlapping areas. 
Furthermore, no GA was delineated in 43 images because it was either not present or 
ungradable, and 26 images were excluded due to poor image quality. The remaining 409 
images were included for development of the model and evaluation of its performance. 
This set contains 87 images from BMES (26 participants, 43 eyes) and 322 images from 
RS (149 participants, 195 eyes). The 409 images represent 315 unique visits (some visits 
had two CFIs available). 
We identified 5,379 images (459 participants, 625 eyes) from the AREDS set with 
GA and at least two years of follow up, following the grading available from the database 
of genotype and phenotype (dbGaP) 2014 table. Most of these images were 
stereoscopic, so this accounted for 2,750 unique acquisitions (eye-visit). Pixel to 
millimeter conversion was fixed for all images, based on the average distance between 
fovea and center of the optic disc measured in a subset of the images. This distance was 
assumed to be 4.5mm.37 
Delineations of GA area were made by four graders (3 of them with over 20 years 
of experience), using an in-house created software platform for manual annotations 
(https://www.a-eyeresearch.nl/software/ophthalmology_workstation/).38 For RS, 
additional multimodal imaging (infrared, FAF and/or OCT) was available for some of the 
visits, and the platform allowed images of the same eye (both multimodal and 
longitudinal) to be aligned manually by identifying corresponding landmarks. The graders 
could simultaneously view images of the same eye using a synchronized cursor on 
multiple screens. GA was identified as absence of the retinal pigment epithelium and 
increased visibility of the choriocapillaris on CFI. Additional evidence from other 
modalities was used whenever available. Areas of macular and peripapillary atrophy 
were delineated as separate classes, but for this study only macular GA was used. 
Each grader annotated the entire BMES set, while the RS set was divided in such 
a way that each grader annotated approximately half of the entire set and every image 
was graded by at least two graders. Finally, a consensus grading was made for all 
images in both sets. During the consensus grading all graders decided together which 
of the individual gradings was most accurate, and updated this grading if necessary, until 
consensus was reached. If two CFIs of the same visit were present, both were included 
for model development and the delineated GA area was propagated from one image to 
the other by using the affine transformation calculated from the manual landmarks. For 
evaluation, only the CFI that was used to make the consensus grading was used. 
Model 
The proposed deep learning model for GA segmentation consisted of an 
ensemble of several models, each trained with partly overlapping training sets. The 
network architecture (the topology of connections between internal parameters of the 
deep-learning model) for each model consisted of a deep encoder-decoder structure with 
residual blocks and shortcut connections, similar to De Fauw et al,39 but adapted to work 
with CFIs. This architecture, and its variations, can be characterized by a contracting 
path, in which the high-resolution input image is converted to a low-resolution abstract 
representation, followed by an expanding path in which the original resolution is 
reconstructed. The contracting and expanding path are connected by shortcut 
connections. This approach has been shown to be very effective for semantic 
segmentation in medical imaging for which large contextual information is required. 
Input to each model was both the original color image and a contrast-enhanced 
version of the same image, both resampled to 512x512 pixels. The contrast-enhanced 
image was obtained by subtracting a blurred image from the original image.40 The input 
was transformed through the many layers of artificial neurons in the contracting and 
expanding path, and ultimately yielded a new image in which the value of every pixel 
represented a likelihood of being part of an area of GA. A threshold was applied to this 
likelihood image to obtain the final GA area. More details about the model and the training 
procedure used for this study can be found in the supplementary material. 
GA segmentation 
For the development and the validation of the model, we applied a five-fold cross-
validation scheme. Data from BMES and RS were merged into one dataset and randomly 
split at patient level into five approximately equal folds. In a rotating scheme, four folds 
were used for model training and validation (development set), while the remaining fold 
was used for performance evaluation (test set). Furthermore, four separate models were 
created within each development set. Each model used three folds for tuning of the 
internal parameters (training) and one for validation. An ensemble of these four models 
was then evaluated on the respective test set. Ultimately, an ensemble of the 20 obtained 
models (four models developed for each of the five rounds) constituted the final model. 
The performance of the model and the agreement between graders were 
assessed using the Dice coefficient, which is defined as two times the intersection of two 
areas divided by the sum of the individual areas. Hence, a value of zero represents 
disjoint areas (no overlap), while a value of one represents perfect agreement. Dice 
coefficients were calculated between graders to assess the inter-observer agreement, 
whereas the areas delineated in the consensus grading were used as reference for the 
model. Note that the consensus grading was not independent of the individual gradings, 
and therefore could not be used as a reference to estimate graders' performance. 
Furthermore, intra-class correlation coefficient (ICC) of the GA area and of the square 
root of the GA area was used to measure agreement between graders and the model. 
GA growth rate 
The final deep learning model (the ensemble of 20 models) was applied to CFIs 
from AREDS for the analysis of GA progression. It is well-documented that GA area 
increases faster for larger lesions. To remove the dependency of baseline lesion size on 
growth rate, many researchers apply a square root transformation to the GA 
area.26 Similarly, we calculated the square root annual growth in millimeter per year for 
each eye to assess progression in the AREDS set.37 This value was obtained from the 
slope of a linear regression through the square root of the GA area for a selected set of 
timepoints. The selected set consisted of all available CFIs within a window of 2 years, 
for which the number of available CFIs was highest for the respective eye. The window 
was limited at 2 years because growth rate and lesion characteristics may change over 
time.23 We calculated the correlation of square root annual growth rate between fellow 
eyes, and compared growth rate between groups using an unpaired t-test for unilateral 
versus bilateral, unifocal versus multifocal and foveal versus extrafoveal cases. 
In order to identify structural characteristics or features that may be predictive for 
growth rate, we built a linear model based on features that were extracted from the 
segmented GA area at baseline (the first image within the selected window). Candidate 
features were area, perimeter, convex area, filled area, solidity (area / convex area ratio 
and area / filled area ratio), number of lesions, eccentricity, circularity, roundness and 
foveal involvement. Details on how these features were calculated can be found in the 
supplementary material. Associations between individual features and square root 
annual growth rate were calculated using univariate linear regression. Because the 
features were not independent, a multivariate linear model was created to further 
investigate which features best explain variation in square root annual growth rate. The 
multivariate model was built using forward selection, by iteratively adding the feature that 
yielded the highest increase in adjusted R² value, until it no further increased. When 
stereoscopic images were available, lesion characteristics were represented by the 
mean of the two calculated values. In order to obtain a more homogeneous set for the 
prediction model, we discarded images where the relative difference in GA area between 
the left and right stereoscopic image was more than 50%, and only included eyes with 
at least 2 years of follow up images. 
Finally, we combined all estimates of GA growth in a single figure. GA growth in 
mm² per year (not square root transformed) was estimated as a function of GA area, 
again using a linear regression for each eye through the GA area in a window of 2 years. 
This resulted in an estimate of GA growth (the slope of the regression), bounded by a 
minimum and maximum GA area. The estimated general GA growth for a given GA area 
was then represented by the mean of all growth estimates for which this GA area fell 
within the respective area bounds. Confidence intervals were estimated using 
bootstrapping.  
Results 
GA segmentation 
The deep learning model reached a Dice coefficient of 0.72 ± 0.26 (N=315), 
measured in cross-validation in the BMES and RS data sets. Dice coefficients between 
two independent graders ranged from 0.72 ± 0.26 to 0.82 ± 0.21 (0.78 ± 0.24 on 
average). See Table 1 for more details. The intraclass correlation coefficient between 
the model and the consensus was 0.83 for GA area, and 0.84 for the square root of the 
GA area. Consistency in those values is further visualized in Figure 1 using Bland-Altman 
plots. The mean value of the differences between consensus and model did not differ 
significantly from 0 on the basis of a 1-sample t-test for neither GA area (p=0.82) nor 
square root GA area (p=0.22). Examples of manually and automatically segmented GA 
areas can be found in Figure 2. More examples of automatic segmentation results on 
the AREDS set can be found in Supplementary Figure 1. 
GA growth rate 
After excluding visits where the difference between left and right stereoscopic 
images in automatically segmented area was more than 50%, 584 of the 625 eyes in 
AREDS with at least 2 years of follow up remained. Square root annual growth of GA for 
those eyes was 0.21 ± 0.46 mm/year. This value was significantly higher for eyes with 
small (<5 mm²) baseline GA area (0.31 ± 0.39, N=308), compared to eyes with large (≥ 
5mm²) baseline GA area (0.10 ± 0.50, N=276), p<0.001. Table 2 shows differences in 
growth rate between groups. We observed that multifocal and extrafoveal lesions grow 
faster than unifocal or foveal lesions. Subjects with bilateral GA showed faster 
progression than unilateral cases, although not significant in our analysis (p=0.12). 
Growth rates between fellow eyes were correlated (r=0.45, p<0.001). Figure 3 highlights 
progression of GA for selected individual eyes. 
Correlations between baseline lesion characteristic and square root annual 
growth are summarized in Table 3. Eight out of eleven features were significantly 
correlated with GA growth rate (after Bonferroni correction). Features included in the 
multivariate model were area, circularity, filled solidity, convex area, number of lesions, 
eccentricity and roundness. The coefficient of determination of this model was 0.18. 
A visualization that summarizes growth over time for all eyes with GA in the 
AREDS set can be found in Figure 4. The red dashed line in these graphs represent a 
quadratic model that best fitted the data for GA area < 12 mm². 
Discussion 
A deep-learning model for segmentation of GA in CFIs was developed and 
evaluated. We demonstrated how the automatically obtained segmentations of the 
model can be used to study growth rate of GA on an independent set. The performance 
of the deep learning model in terms of Dice coefficient on the BMES and RS set 
approached that of human experts. The model was able to identify GA even when image 
quality or contrast were relatively poor, as demonstrated in Figure 2. Nevertheless, some 
failure cases were still present, which was the main reason for the lower average Dice 
coefficient. We suspect that more training data may solve this issue, since each of the 
models only used 60% of the data (~245 images) for training, which may not be enough 
given the inherent difficulty of the problem and the variability in the data. For application 
to the AREDS set this problem was partly circumvented by using an ensemble model, 
which indirectly made use of all training data. 
The obtained mean square root annual growth rate on the AREDS set (0.21 ± 
0.46 mm/year) was slightly lower than previously reported values. For example, 
Domalpally et al. observed 0.30 mm/year,29 and Keenan et al. observed 0.28 
mm/year.41 A reason for this may be the dependence of growth rate on baseline area. 
When we split the dataset on baseline lesion size, we observed that small lesions have 
larger square root growth rates (see Table 2). This phenomenon was analyzed in more 
detail in Figure 4. A quadratic curve seemed to fit the observed GA progression very well 
up to an area of around 12 mm². For larger areas, the growth rate seemed to stabilize or 
even decrease. Similar observations were made by Keenan et al.41, whose reported 
values are included in Figure 4 for comparison. 
The importance of baseline area for assessing growth rate also became apparent 
in the regression analysis, where area, filled area and convex area were most strongly 
correlated with square root annual growth rate. However, when we included only lesions 
with baseline area < 12mm² in the regression analysis, no features related to lesion size 
were significantly associated with square root annual growth rate. On an individual level, 
we also observed a quadratic growth of the area of GA in many cases in the AREDS set, 
some of them highlighted in Figure 3, where we fitted a quadratic curve through the GA 
area over time. Again, the decrease in growth rate for larger lesions was visible (bottom 
two cases in Figure 3). 
Of the features that are invariant to lesion size, convex solidity was most 
significantly associated with square root annual growth rate. Convex solidity is low for 
irregular shaped lesions, but also for multifocal lesions. This feature hence captures 
multiple previously reported associations. Circularity was previously associated with GA 
growth rate,23 but compared to other features, the association was not very strong in our 
analysis. An explanation is that the model may have produced a segmentation with a 
very jagged border for some lesions with indistinct borders of the atrophic area. This 
could have led to a relatively large perimeter, and hence a lower value for circularity. 
Roundness will be a better representation of how well the lesion approaches a circular 
shape in those cases, as it represents the ratio of the area of an enclosing circle and the 
area of the lesion, and is hence less sensitive to irregular borders.42 
A limitation of our study was that the conversion from pixels to millimeters may 
have been inaccurate. This conversion was based on the average distance between 
fovea and optic disk in a subset of images. Although it is unlikely that this inaccuracy was 
a source for bias in reported associations with growth rate, reported values for area and 
growth rate may be slightly larger or smaller in reality. 
In the future, we will extend the model to other modalities, specifically FAF and 
OCT. This may give more accurate measurements of the atrophic area, and hence more 
reliable assessment of growth rate. In this study, only morphological features of the 
atrophic area were considered. A next step would be to include associations between 
growth rate and other lesions patterns, especially those visible on FAF or OCT. Finally, 
we are investigating the capabilities of deep learning models to directly predict areas 
where GA may develop. This will provide predictions of both the extent and the location 
of future GA area. 
In conclusion, we have presented and validated a robust segmentation model 
based on deep learning for GA in CFIs. The model was capable of reproducing known 
associations between current GA status and future growth. Moreover, we indicated novel 
structural biomarkers that are predictive for future growth rate, such as solidity, 
eccentricity or roundness of the lesion. We demonstrated how deep learning can help in 
the automation of grading, allowing for analysis of larger datasets and helping to 
understand progression of GA. 
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Table 1: Dice coefficients between model and consensus grading, and between 
individual graders. 
 
 
 
 
 
  
 N Dice coefficient 
Model – Consensus 315 0.72 ± 0.26 
Grader 1 – Grader 2 146 0.80 ± 0.27 
Grader 1 – Grader 3 138 0.78 ± 0.27 
Grader 1 – Grader 4 90 0.72 ± 0.26 
Grader 2 – Grader 3 91 0.82 ± 0.21 
Grader 2 – Grader 4 134 0.78 ± 0.22 
Grader 3 – Grader 4 130 0.78 ± 0.19 
Table 2: Square root annual growth of the GA area. Values represent mean ± 
standard deviation. P-values are calculated using an unpaired t-test. 
 
  
 Square root annual growth (mm/year) 
 All Small (<5mm2) Large (≥5mm2) 
overall 0.21 ± 0.46 (N:584) 0.31 ± 0.39 (N:308) 0.10 ± 0.50 (N:276) 
unifocal 0.18 ± 0.41 (N:401) 0.26 ± 0.33 (N:201) 0.10 ± 0.46 (N:200) 
multifocal 0.28 ± 0.54 (N:183) 0.39 ± 0.47 (N:107) 0.12 ± 0.59 (N:76) 
P-value 0.017 0.005 0.784 
foveal 0.18 ± 0.45 (N:459) 0.28 ± 0.35 (N:192) 0.10 ± 0.50 (N:267) 
extrafoveal 0.33 ± 0.44 (N:125) 0.35 ± 0.44 (N:116) 0.12 ± 0.28 (N:9) 
P-value 0.001 0.131 0.900 
unilateral 0.18 ± 0.47 (N:217) 0.26 ± 0.36 (N:115) 0.10 ± 0.54 (N:102) 
bilateral 0.23 ± 0.45 (N:367) 0.32 ± 0.41 (N:193) 0.14 ± 0.47 (N:174) 
P-value 0.123 0.386 0.174 
Table 3: Correlations between baseline lesion characteristics (features) and 
square root annual growth rate (in mm/year). Features are sorted in decreasing order of 
strength of association. A P-value smaller than 0.0045 (0.05, Bonferroni corrected) is 
considered significant 
Feature R2 Slope Intercept R P Std 
error 
Area            0.115 -0.016 0.365 -0.339 <0.001 0.002 
Filled area     0.114 -0.015 0.365 -0.338 <0.001 0.002 
Convex area     0.097 -0.013 0.363 -0.312 <0.001 0.002 
Convex solidity        0.086 -0.814 0.891 -0.294 <0.001 0.132 
Eccentricity    0.069 0.677 -0.194 0.263 <0.001 0.124 
Roundness             0.065 -0.706 0.72 -0.255 <0.001 0.133 
Fovea region    0.045 -3.045 0.373 -0.213 <0.001 0.695 
Perimeter       0.045 -0.008 0.363 -0.213 <0.001 0.002 
Number of 
lesions       0.016 0.057 0.144 0.127 0.011* 0.022 
Circularity 0.014 -0.227 0.338 -0.119 0.017* 0.095 
Filled solidity     0.004 1.445 -1.198 0.062 0.212* 1.154 
* Not significant       
Figure 1: Bland-Altman plot of GA area (left) and square root GA area (right). 
Differences are calculated as the area/square root area of the consensus grading minus 
the automatic segmentation. 
 
 
 
  
Figure 2: Examples of automatic GA segmentation. The green area corresponds 
to either the consensus (left) or the model output (right). The top three rows show 
accurate segmentation results, for various configurations of GA differing in area, shape 
and number of lesions, and variable image quality and contrast. The bottom row shows 
examples of inaccurate model output. 
 
 
  
Figure 3: Progression of GA over time for 4 selected eyes. The graphs represent 
area measurements over time (two points per timepoint for the LS and RS stereoscopic 
images). The blue line is a quadratic fit through the points. For the top 2 cases, an 
increment in growth rate can be observed. 53834 LE has a more irregular shape than 
51551 RE and progresses faster. In the bottom two cases we observe that the growth 
decreases as the GA area gets larger.  
 
 
  
Figure 4: GA growth over time. Left: GA growth rate (in mm2/year) as a function 
of GA area. The blue line represents growth rates estimated from the segmentations of 
the deep learning model. The shaded area represents the 95% confidence interval 
(estimated using bootstrapping). The dashed red line represents the growth rate of a 
quadratic model, as visualized in the right graph. Right: the blue line represents the 
evolution of GA area over time, obtained by numerically integrating the estimated growth 
rates from the left graph using a GA area of 0.5 mm2 at t=0. The red dashed line 
represents the best quadratic fit to the plot for GA area < 12 mm2. Above this area the 
observed GA area diverges from the quadratic fit. 
 
  
Appendix 
Deep learning model details 
The deep learning architecture consisted of an encoder-decoder structure with 
eight levels of resolution, connected by shortcut connections at every level. At every level 
of resolution, a residual block with two 3x3 convolutions was used. The number of filters 
per convolution was, for each of the respective levels 32, 32, 64, 64, 128, 128, 256, 256. 
The eight levels of down-sampling reduce the input from 512x512 to a feature map of 
2x2 pixels. At the lowest level, two residual blocks with 1x1 convolutions and 2048 filters 
each were applied. The down-sampling operations were performed by strided 
convolutions.  
Binary cross-entropy was used as loss-function. During the first 10 epochs, the 
loss was weighted to balance the classes. The model was trained on batches of 2 
images, using the adam-optimizer with a learning rate of 32 * 10-5. The learning rate was 
divided by two every 50 epochs. Input images were augmented by horizontal and vertical 
flipping, scaling of up to 1.3, rotations of maximum 40 degrees, and translations of up to 
150 pixels.  
The best model for each of the subsets in the cross-validation scheme was 
selected based on best performance on the respective validation set. Performance was 
assessed as best average Dice-coefficient after selecting the optimal threshold. The 
ensemble model was constructed by combining the output of the models after correcting 
for differences in optimal threshold between models: 
𝑦 =∑𝑦𝑘
log⁡(2)⁡/⁡log(𝑡ℎ𝑘)⁡
𝑘
 
Where 𝑦 represents the final prediction for a specific pixel, 𝑦𝑘represents the 
prediction for that pixel for model 𝑘 and 𝑡ℎ𝑘 represents the optimal threshold for model 
𝑘. 
Implementation and training of the model was done using the keras library1 with 
tensorflow backend.2 
1. Chollet, F. et al., Keras, https://keras.io, 2015; 
2. Abadi, M. et al. TensorFlow: Large-scale machine learning on heterogeneous 
systems, https://www.tensorflow.org, 2015  
Description of lesion characteristics 
Area: The total area of all segmented GA. 
Perimeter: The total perimeter along the border of the segmented area. If lesions 
have holes, the perimeter along inner borders are also included. Four-connectivity for 
border pixel determination is used. 
Convex area: The area of the convex hull of all lesions: multifocal lesions are 
joined rather than calculating the convex hull for each focus separately. 
Filled area: The area of the segmented GA with holes filled. 
Convex solidity: The ratio of area and convex area. 
Filled solidity: The ratio of area and filled area. 
Number of lesions: The number of separate lesions with a diameter of at least 
0.175 mm. Lesions are separated if pixels do not touch neither horizontally, vertically or 
diagonally. 
Eccentricity: Eccentricity of the ellipse that has the same second-moments as 
the GA region. The eccentricity is the ratio of the focal distance (distance between focal 
points) over the major axis length.  
Circularity: Calculated as 4π area / perimeter². 
Roundness: The ratio of the actual GA area and the area of an enclosing circle, 
calculated as 4 area / π d², where d is the length of the major axis of the ellipse that has 
the same second central moments as the region. 
Foveal involvement: The intersection area of the segmented GA area and a 
circular area with diameter of 0.3 mm in the center of the image. 
All lesion characteristics were calculated using Python 3.7, with the numpy library, 
version 1.15.3 (https://numpy.org/) and the scikit-image library, version 0.14.1 
(https://scikit-image.org/) 
  
Figure S1: Sample showing the output of the model for the first 20 patients in the 
AREDS set (showing the first image with label GA for every patient). 
 
